Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy - Wikidata - wikimedia - TriplyDB

Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy

Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy

http://www.wikidata.org/entity/Q35083186

about

The evolving concept of physiological ischemia training vs. ischemia preconditioning Interleukin-4 and melatonin ameliorate high glucose and interleukin-1β stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells.S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy Influence of uncomplicated phacoemulsification on central macular thickness in diabetic patients: a meta-analysis.Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.Current concepts regarding developmental mechanisms in diabetic retinopathy in Taiwan.Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology Association of HMGB1 with oxidative stress markers and regulators in PDR.The G-Protein-Coupled Chemoattractant Receptor Fpr2 Exacerbates High Glucose-Mediated Proinflammatory Responses of Müller Glial Cells.Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy.Association of plasma osteopontin with diabetic retinopathy in Asians with type 2 diabetes.Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy.Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.Myeloid-Related Protein-14/MRP-14/S100A9/Calgranulin B is Associated with Inflammation in Proliferative Diabetic Retinopathy.Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.Alterations in the polysialylated neural cell adhesion molecule and retinal ganglion cell density in mice with diabetic retinopathy

P2860

Q26776276-CFABB6D9-4F3D-488A-849C-51C1C08B72FD Q33830291-65237EB4-B15D-4421-95B7-02EC089732F5 Q34161174-0DC6AA87-8006-47A4-A6BC-9D9922D2C626 Q34941725-EC07336F-07B5-47ED-B847-831887F0B254 Q35627920-837E1AC1-20A4-4309-863B-2A6FAFBE123C Q36088748-41049172-634D-4BDD-895C-4406509BED9D Q36853911-B49970F3-8D66-4C75-89DB-19459713EF1E Q36877327-43F29423-E811-4EBB-BD59-BC546FEF1026 Q38365800-1BDDC74B-CBF2-4127-A248-EC257C57A6E3 Q41374334-4F7F37D3-C02C-49F6-B717-8DF88A0B9E45 Q47108366-5D6D874A-4EE6-4C89-978A-ED02B7C85F92 Q47221154-0E23DF21-E692-47C9-A171-42401B2CABC1 Q48300010-2A16C431-FC64-4D3C-B285-0921B22FA5ED Q49788518-7A61A16F-ED23-4108-8FD0-17348A297025 Q50069408-E3C2F80F-013A-40FA-B88D-186D9A83FD18 Q50071959-F502FDD4-10F9-4179-8981-3D1425C9302A Q51016986-A109BC4A-8EE3-4CA6-8D99-D5C83C432B0D Q51319850-1BF8B6B5-6401-478A-B457-4805B12EAD70 Q51324995-03799270-0E83-4B12-A019-ECD944C3D75B Q55097343-E8A77E41-BA3C-484E-AE7B-D0057A051C64 Q58597208-E3357640-2224-4862-B965-140D1E7221F2

P2860

Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy

http://www.wikidata.org/entity/Q35083186

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Relationship between vitreous ...... iferative diabetic retinopathy

@ast

Relationship between vitreous ...... iferative diabetic retinopathy

@en

type

label

Relationship between vitreous ...... iferative diabetic retinopathy

@ast

Relationship between vitreous ...... iferative diabetic retinopathy

@en

prefLabel

Relationship between vitreous ...... iferative diabetic retinopathy

@ast

Relationship between vitreous ...... iferative diabetic retinopathy

@en

P1433

Q35083186-60279175-A7D6-4DC4-A608-568C21E980B2

P1476

Q35083186-377C64F7-677E-4DE2-B53A-FB14A0496FB3

P2093

Q35083186-5CEEA6E3-01B0-4B40-B76B-A563E06FD431

Q35083186-85DEB1C6-8725-4FD2-BD7E-169C930632C1

Q35083186-9D9455A1-A135-4FA4-84ED-7647F357D1D4

P2860

Q35083186-1DC89D05-A5E8-4AA3-8F26-367641434923

Q35083186-21C83B56-A572-48B4-ABE0-810A221BE85F

Q35083186-2CD48E90-A900-4D17-8612-DE43DA78D16C

Q35083186-3522CD29-38C2-4EAE-8644-23C3A831E31D

Q35083186-39447034-FF0D-4949-92BD-C1328600B6F4

Q35083186-3AACE021-CE34-428C-815B-DE8BE1B8FFA7

Q35083186-43FF07FC-DAAE-4264-8ED9-66ADB75A4D63

Q35083186-5396A7DB-2A92-4C75-B5FE-984DF9B1D7CB

Q35083186-569D8D37-A2D1-48E9-91B4-8991E0AA5FCC

Q35083186-5B46A3D2-4A5F-4A14-BA16-52F367BB9C86

P304

Q35083186-C224B445-B542-4725-ABE4-20596C9FB2A1

P31

Q35083186-EDCCA932-81D0-4192-AE65-B5CEA6114713

P356

Q35083186-C20622EC-B5DF-4183-957C-4C0E01618397

P407

Q35083186-88F8160E-82F1-4E8B-83FA-1EA051B67D41

P433

Q35083186-CFB78441-020C-4B26-A148-7F119CF84037

P478

Q35083186-17A8F950-77FF-4B5B-BCE6-B0D3273B7D2F

P50

Q35083186-01DD862E-3214-4E56-AACC-5376129109E5

Q35083186-295D712E-F4C0-40D6-BDE0-1FE8A8DDF02E

Q35083186-AD4C1286-BFED-49E0-A94B-5E170FEDFF95

Q35083186-BB74BCB4-A782-4462-8986-2D9B1A3F6D1B

Q35083186-EF69D2BE-DC15-46B0-8FDD-F9D8B2832F6E

P577

Q35083186-94C53243-3DC5-4835-8F82-390E3B36AE9B

P5875

Q35083186-292AD48E-41B3-4BF8-962C-20942AD41253

P698

Q35083186-8C3FFED0-A9DA-4161-AAC8-7475AB9850CB

P921

Q35083186-661C3C54-70FE-474D-9A42-8FCA56E557AF

P932

Q35083186-E82A19E6-181F-49F4-9536-9BFA5451243D

P356

JOURNAL.PONE.0085857

P1433

P1476

Relationship between vitreous ...... iferative diabetic retinopathy

@en

P2093

Ahmed M Abu El-Asrar

http://www.w3.org/2001/XMLSchema#string

Ahmed Mousa

http://www.w3.org/2001/XMLSchema#string

Mohammad Mairaj Siddiquei

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade

Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo

Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.

Matrix metalloproteinases in human diabetic and nondiabetic vitreous.

Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.

Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells

New concepts in pathogenesis and treatment of diabetic retinopathy.

Zymography methods for visualizing hydrolytic enzymes.

Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation.

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.

P304

e85857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0085857

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Gert De Hertogh

Ghislain Opdenakker

Kathleen Van den Eynde

Ghulam Mohammad

P577

2013-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259589514

http://www.w3.org/2001/XMLSchema#string

P698

24392031

http://www.w3.org/2001/XMLSchema#string

P921

P932

3877391

http://www.w3.org/2001/XMLSchema#string